| Literature DB >> 24281257 |
Yoshifumi Fukunishi1, Haruki Nakamura.
Abstract
We have developed a method for estimating protein-ligand binding free energy (DG) based on the direct protein-ligand interaction obtained by a molecular dynamics simulation. Using this method, we estimated the DG value statistically by the average values of the van der Waals and electrostatic interactions between each amino acid of the target protein and the ligand molecule. In addition, we introduced fluctuations in the accessible surface area (ASA) and dihedral angles of the protein-ligand complex system as the entropy terms of the DG estimation. The present method included the fluctuation term of structural change of the protein and the effective dielectric constant. We applied this method to 34 protein-ligand complex structures. As a result, the correlation coefficient between the experimental and calculated DG values was 0.81, and the average error of DG was 1.2 kcal/mol with the use of the fixed parameters. These results were obtained from a 2 nsec molecular dynamics simulation.Entities:
Year: 2012 PMID: 24281257 PMCID: PMC3816655 DOI: 10.3390/ph5101064
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Cross-validation results obtained by Equation (10) and the DIAV method (Equation (11)).
| Statistics | ΔGsimple (Equation 10) | ELE a | vdW a | ASA a | DIH a |
|---|---|---|---|---|---|
| Average error (kcal/mol) | 2.22 | 2.30 | 1.85 | 2.06 | 1.94 |
| R | 0.72 | 0.70 | 0.72 | 0.71 | 0.67 |
| α | 0.22 | 0.22 | 0.18 | 0.17 | 0.15 |
| β | 0.017001 | 0.016411 | 0.005958 | 0.012600 | 0.010430 |
| τ*100 | - | −0.078460 | −28.506610 | −0.026605 | −0.000696 |
The vdW potential is the LJ 12-6 type. a: property (x) of Equation (11). Here α2 = β2 = 0. The energies are presented in kcal/mol, and R represents the correlation coefficient.
Cross-validation results obtained by the DIAV method (Equation (11)) to examine the van der Waals potential type.
| Statistics | LJ9-6 | LJ8-4 | LJ6-3 |
|---|---|---|---|
| Average error (kcal/mol) | 2.26 | 1.75 | 1.89 |
| R | 0.69 | 0.76 | 0.71 |
| α | 0.1727 | 0.0428 | 0.0066 |
| β | 0.0139 | 0.0072 | 0.0078 |
| τ*10000 | −2.9273 | −2.5677 | −2.8531 |
The energies are presented in kcal/mol, and R represents the correlation coefficient.
Cross-validation results obtained by the DIAV method (Equation (11)) to examine α2 and β2 parameters.
| Statistics | ASA | DIH |
|---|---|---|
| Average error (kcal/mol) | 1.63 | 1.59 |
| R | 0.80 | 0.76 |
| α | 0.04146 | 0.03832 |
| β | 0.00643 | 0.00491 |
| τ*10000 | −2.74887 | −0.06949 |
| α2 | 0.0093 | 0.0093 |
| β2 | −0.0013 | −0.0015 |
The vdW potential is the LJ 8-4 type. The energies are presented in kcal/mol, and R represents the correlation coefficient.
Cross-validation results obtained by Equation (10), the DIAV (Equation (11)), and the DIAS (Equation (16)) methods.
| PDB ID | ΔGexptl (kcal/mol) | ΔGsimple (Equation (10)) (kcal/mol) | ΔGDIAV (Equation (11)) (kcal/mol) | ΔGDIAS (Equation (16)) (kcal/mol) |
|---|---|---|---|---|
| 1abe | −9.57 | −5.46 | −6.27 | −6.68 |
| 1abf | −7.39 | −6.30 | −6.67 | −6.90 |
| 1apu | −10.50 | −13.50 | −11.98 | −11.76 |
| 1dbb | −12.27 | −8.75 | −11.79 | −11.69 |
| 1dbj | −10.47 | −8.35 | −12.27 | −12.10 |
| 1dog | −5.48 | −5.40 | −6.09 | −6.12 |
| 1dwb | −3.98 | −3.69 | −4.83 | −5.05 |
| 1epo | −10.85 | −17.25 | −14.82 | −15.56 |
| 1etr | −10.09 | −9.91 | −10.35 | −10.08 |
| 1ets | −11.62 | −11.05 | −11.82 | −11.52 |
| 1ett | −8.44 | −9.46 | −9.99 | −9.75 |
| 1hpv | −12.57 | −14.02 | −12.88 | −12.78 |
| 1hsl | −9.96 | −6.53 | −6.74 | −7.18 |
| 1htf | −11.04 | −12.45 | −11.12 | −11.00 |
| 1hvr | −12.97 | −16.98 | −14.67 | −14.95 |
| 1nsd | −7.23 | −7.44 | −8.33 | −8.13 |
| 1pgp | −7.77 | −11.01 | −11.09 | −10.24 |
| 1phg | −11.81 | −6.88 | −8.03 | −8.22 |
| 1ppc | −8.80 | −9.83 | −8.66 | −8.85 |
| 1pph | −8.49 | −8.50 | −7.87 | −8.00 |
| 1rbp | −9.17 | −9.29 | −8.58 | −8.91 |
| 1tng | −4.00 | −4.15 | −4.64 | −4.90 |
| 1tnh | −4.59 | −3.54 | −4.24 | −4.61 |
| 1ulb | −7.23 | −3.82 | −5.71 | −5.74 |
| 2cgr | −9.92 | −7.07 | −10.94 | −10.88 |
| 2gbp | −10.36 | −8.95 | −9.27 | −9.77 |
| 2ifb | −7.41 | −9.57 | −8.53 | −8.38 |
| 2phh | −6.38 | −4.09 | −6.83 | −6.79 |
| 2r04 | −8.48 | −10.39 | −10.31 | −10.26 |
| 2tsc | −11.62 | −11.05 | −8.68 | −8.28 |
| 2ypi | −6.58 | −5.40 | −5.72 | −6.45 |
| 3ptb | −6.46 | −4.93 | −5.02 | −4.55 |
| 4dfr | −13.23 | −11.52 | −13.93 | −13.52 |
| 5abp | −9.05 | −6.64 | −7.19 | −7.59 |
| Averageerror | - | 1.88 | 1.30 | 1.22 |
| R | - | 0.73 | 0.81 | 0.81 |
| α | - | 0.0503 | 0.0378 | 0.0307 |
| β | - | 0.0125 | 0.0082 | 0.0118 |
| τ∗10000 | - | - | −2.4178 | −2.4312 |
| α2 | - | - | 0.0093 | 0.01 |
| β2 | - | - | −0.0011 | −0.00312 |
| x | - | - | - | 0.6 |
The vdW potential is the LJ 8-4 type. The property x of Sx is the ASA. The energies are presented in kcal/mol, and R represents the correlation coefficient.
Figure 1Cross-validation results obtained by the DIAV method. The experimental data (ΔGexptl) and the calculated value (ΔGDIAV).
Docking accuracy.
| Initial structure (intact PDB coordinates: model 1) | Top ΔG structure by the DIAS method | Top scoring structure by Sievgene | Best among the top 5 structures |
|---|---|---|---|
| RMSD < 1 Å | 29.4% | 35.3% | 47.1% |
| RMSD < 2 Å | 41.2% | 76.5% | 94.1% |
| RMSD < 3 Å | 47.1% | 94.1% | 94.1% |
|
|
|
|
|
| RMSD < 1 Å | 40.0% | 6.7% | 66.7% |
| RMSD < 2 Å | 73.3% | 46.7% | 93.3% |
| RMSD < 3 Å | 80.0% | 73.3% | 93.3% |
|
|
|
|
|
| RMSD < 1 Å | 20.0% | 0.0% | 0.0% |
| RMSD < 2 Å | 33.3% | 33.3% | 33.3% |
| RMSD < 3 Å | 53.3% | 46.7% | 66.7% |
The vdW potential is the LJ 8-4 type. The property x of Sx is the ASA.
List of the proteins used.
| PDB ID | Protein |
|---|---|
| 1abe | L-ARABINOSE-BINDING PROTEIN |
| 1abf | L-ARABINOSE-BINDING PROTEIN |
| 1apu | ACID PROTEINASE (PENICILLOPEPSIN) |
| 1dbb | FAB' FRAGMENT |
| 1dbj | FAB' FRAGMENT |
| 1dog | GLUCOAMYLASE |
| 1dwb | THROMBIN |
| 1epo | ENDOTHIA ASPARTIC PROTEINASE |
| 1etr | THROMBIN |
| 1ets | THROMBIN |
| 1ett | THROMBIN |
| 1hpv | HIV-1 PROTEASE |
| 1hsl | HISTIDINE-BINDING PROTEIN |
| 1htf | HIV-1 PROTEASE |
| 1hvr | HIV-1 PROTEASE |
| 1nsd | NEURAMINIDASE |
| 1pgp | 6-PHOSPHOGLUCONATE DEHYDROGENASE |
| 1phg | CYTOCHROME P450 |
| 1ppc | TRYPSIN |
| 1pph | TRYPSIN |
| 1rbp | RETINOL-BINDING PROTEIN |
| 1tng | TRYPSIN |
| 1tnh | TRYPSIN |
| 1ulb | PURINE NUCLEOSIDE PHOSPHORYLASE |
| 2cgr | IGG2B (KAPPA) FAB FRAGMENT |
| 2gbp | D-GALACTOSE/D-GLUCOSE-BINDING PROTEIN |
| 2ifb | INTESTINAL FATTY ACID BINDING |
| 2phh | P-HYDROXYBENZOATE HYDROXYLASE |
| 2r04 | RHINOVIRUS 14 (HRV14) |
| 2tsc | THYMIDYLATE SYNTHASE |
| 2ypi | TRIOSE PHOSPHATE ISOMERASE |
| 3ptb | TRYPSIN |
| 4dfr | DIHYDROFOLATE REDUCTASE |
| 5abp | L-ARABINOSE-BINDING PROTEIN |